Walgreens Boots Alliance, Inc.

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
18.12 ^USD	+5.41%		+4.98%	-30.60%

May. 13	Equities Close Mixed as Markets Weigh Consumer Inflation Survey	MT
May. 13	Equities Close Mixed as Markets Parse Consumer Inflation Survey	MT

Walgreens reaches $230 million opioid settlement with San Francisco

May 17, 2023 at 02:29 pm EDT

(Reuters) - Walgreens has reached a $230 million settlement with San Francisco over its alleged role in that city's opioid epidemic, city attorney David Chiu said on Wednesday.

Chiu said in Twitter posts the accord followed a trial where the court found Walgreens substantially contributed to the epidemic and created a public nuisance.

(Reporting by Jonathan Stempel in New York; Editing by Chris Reese)

Latest news about Walgreens Boots Alliance, Inc.

Equities Close Mixed as Markets Weigh Consumer Inflation Survey	May. 13	MT
Equities Close Mixed as Markets Parse Consumer Inflation Survey	May. 13	MT
Equities Mixed Intraday as Markets Analyze Consumer Inflation Survey	May. 13	MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading	May. 13	MT
Increasing Short-Term Inflation Expectations Weigh on US Equity Indexes Ahead of Consumer, Producer Prices	May. 13	MT
US Equity Indexes Trade Mixed as Short-Term Inflation Expectations Increase	May. 13	MT
Walgreens Seeking Buyers for Boots Chain	May. 13	MT
Walgreens seeks out potential buyers for sale of its UK Boots pharmacy chain, Bloomberg reports	May. 13	RE
Walgreens Seeking Buyers for Boots Chain	May. 13	MT
Walgreens Seeking Buyers for Boots Chain	May. 13	MT
Walgreens Seeking Buyers for Boots Chain, Bloomberg Says	May. 13	MT
HSBC Adjusts Price Target on Walgreens Boots Alliance to $16 From $20	May. 09	MT
Zebra Technologies first-quarter results beat estimates	Apr. 30	RE
CVS Omnicare staff in Las Vegas vote to join new union	Apr. 26	RE
Morgan Stanley Adjusts Price Target on Walgreens Boots Alliance to $16 From $20	Apr. 26	MT
Walgreens Boots Alliance Keeps Quarterly Dividend at $0.25 Per Share, Payable June 12 to Shareholders of Record May 21	Apr. 25	MT
Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024	Apr. 25	CI
Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business	Apr. 24	CI
DoorDash Partners With WalGreens to Offer Payment Option for SNAP Customers in US	Apr. 24	MT
DoorDash and Walgreens Launch Unprecedented Access for SNAP Customers	Apr. 24	CI
Truist Securities Adjusts Price Target on Walgreens Boots Alliance to $20 From $25	Apr. 15	MT
RBC Capital Cuts Walgreens Boots Alliance's Price Target to $22 From $26, Sector Perform Rating Kept	Apr. 12	MT
UBS Cuts Walgreens Boots Alliance's Price Target to $22 From $25, Maintains Neutral Rating	Apr. 03	MT
Economic Data Leave Equity Markets Mixed; Yields Surge	Apr. 01	MT
Economic Data Leave Equity Markets Mixed; Yields Surge	Apr. 01	MT

Chart Walgreens Boots Alliance, Inc.

Duration

Period

More charts

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).

Sector

Drug Retailers

Calendar

2024-05-19 - Ex-dividend day

Related indices

Dow Jones Industrial , S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Walgreens CEO on Narrowed Forecast, Shoppers Cutting Back Spending

March 28, 2024 at 03:59 pm EDT

Walgreens Boots Alliance, Inc. first light at the end of the tunnel?

November 27, 2023 at 10:22 am EST

More Strategies

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

18.12 USD

Average target price

22.77 USD

Spread / Average Target

+25.67%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
WALGREENS BOOTS ALLIANCE, INC.	-30.60%	15.63B
JD HEALTH INTERNATIONAL INC.	-22.12%	12.43B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-24.53%	6.57B
YIFENG PHARMACY CHAIN CO., LTD.	+15.41%	6.46B
MATSUKIYOCOCOKARA & CO.	-10.63%	6.04B
NAHDI MEDICAL COMPANY	-2.48%	4.63B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+60.00%	4.61B
CLICKS GROUP LIMITED	-6.67%	3.94B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-10.60%	3.51B
WELCIA HOLDINGS CO., LTD.	-6.20%	3.04B

Other Drug Retailers

Walgreens Boots Alliance, Inc.

Equities

WBA

US9314271084

Drug Retailers

Walgreens reaches $230 million opioid settlement with San Francisco

EPS Revisions